These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34268709)

  • 21. Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis.
    Simpson EL; de Bruin-Weller M; Eckert L; Whalley D; Guillemin I; Reaney M; Chen Z; Nelson L; Qin S; Bansal A; Gadkari A
    Dermatol Ther (Heidelb); 2019 Dec; 9(4):799-805. PubMed ID: 31641952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.
    Wollenberg A; Nakahara T; Maari C; Peris K; Lio P; Augustin M; Silverberg JI; Rueda MJ; DeLozier AM; Pierce E; Yang FE; Sun L; Ball S; Tauber M; Paul C
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1543-1552. PubMed ID: 33834521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey.
    Thai S; Barlow S; Lucas J; Piercy J; Zhong Y; Zhuo J; Wu JJ
    Dermatol Ther (Heidelb); 2023 Jun; 13(6):1289-1303. PubMed ID: 37253874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Pierce E; Feely M; Atwater AR; Schrader A; Jones EA; Dave SS; Simpson EL
    J Dermatolog Treat; 2023 Dec; 34(1):2246601. PubMed ID: 37691405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia-Pacific Region: A Cross-sectional Survey.
    Chu CY; Chan Y; Wananukul S; Cheng H; Chandran NS; Bhat R; Son SW; Liao HF; Gardiner S; Ng QQ; Yeo SH; Chen SB; Kataoka Y
    Dermatol Ther (Heidelb); 2024 Sep; 14(9):2479-2493. PubMed ID: 39103673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].
    Haufe E; Abraham S; Heratizadeh A; Harder I; Zink A; Weisshaar E; Kleinheinz A; von Kiedrowski R; Worm M; Bell M; Wollenberg A; Neubert K; Staubach-Renz P; Hilgers M; Bieber T; Fell I; Homey B; Effendy I; Mempel M; Schäkel K; Beissert S; Weidinger S; Werfel T; Schmitt J
    Hautarzt; 2018 Oct; 69(10):815-824. PubMed ID: 30191254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY; Chiesa Fuxench ZC
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):340-347. PubMed ID: 30025911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A.
    Andersen L; Nyeland ME; Nyberg F
    Br J Dermatol; 2020 May; 182(5):1176-1183. PubMed ID: 31437300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
    Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
    JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis.
    Simpson EL; de Bruin-Weller M; Bansal A; Chen Z; Nelson L; Whalley D; Prescilla R; Guillemin I; Delevry D
    Dermatol Ther (Heidelb); 2021 Aug; 11(4):1415-1422. PubMed ID: 34046851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K; Funk M; Hering M; Lang J; Merhand S; Manion R; Orevillo K; Picozza M; Proctor A; Schwennesen T; Begolka WS; Tullos K; Talent C; Tu M; Vastrup AS; Schwartz A
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):264-273.e1. PubMed ID: 36332836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-being.
    Rademaker M; Jarrett P; Murrell DF; Sinclair RD; Pasfield L; Poppelwell D; Shumack S
    Australas J Dermatol; 2024 Sep; 65(6):e145-e155. PubMed ID: 38773888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.
    Barrett A; Hahn-Pedersen J; Kragh N; Evans E; Gnanasakthy A
    Patient; 2019 Oct; 12(5):445-459. PubMed ID: 31270775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial.
    Kabashima K; Matsumura T; Komazaki H; Kawashima M;
    Dermatol Ther (Heidelb); 2023 Apr; 13(4):997-1011. PubMed ID: 36905481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan.
    Otsuka A; Wang C; Torisu-Itakura H; Matsuo T; Isaka Y; Anderson P; Piercy J; Austin J; Marwaha S; Tanaka A
    Int J Dermatol; 2024 Nov; 63(11):e322-e334. PubMed ID: 38812086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life and disease severity are correlated in patients with atopic dermatitis.
    Kim DH; Li K; Seo SJ; Jo SJ; Yim HW; Kim CM; Kim KH; Kim DW; Kim MB; Kim JW; Ro YS; Park YL; Park CW; Lee SC; Cho SH
    J Korean Med Sci; 2012 Nov; 27(11):1327-32. PubMed ID: 23166413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole.
    Ständer S; Yosipovitch G; Bushmakin AG; Cappelleri JC; Luger T; Tom WL; Ports WC; Zielinski MA; Tallman AM; Tan H; Gerber RA
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1742-1746. PubMed ID: 31132182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.
    Fasseeh AN; Elezbawy B; Korra N; Tannira M; Dalle H; Aderian S; Abaza S; Kaló Z
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2653-2668. PubMed ID: 36197589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.